One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Technical Principles and Functions of Gene SequencingDecember 1, 2022Gene sequencing is a new type of genetic testing technology, which can analyze and determine the full sequence of genes from blood or saliva, predict the possibility of suffering from various diseases...view
What is a Microfluidic Chip?September 27, 20221. Basic definition of microfluidic chipMicrofluidic chip, also known as Lab-on-chip, is a science and technology characterized by the manipulation of fluids in the micron-scale space.At present, the ...view
Next Generation Sequencing (NGS) TechnologyApril 8, 2024Next Generation Sequencing (NGS), also known as high-throughput sequencing, revolutionized the field of genomics. Unlike traditional Sanger sequencing methods, NGS allows researchers to analyze vast a...view